HYPERVITAMINOSIS B12

This adverse event was reported 11 times

HYPERVITAMINOSIS B12 is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TALIMOGENE LAHERPAREPVEC 1 0.0006
1 PENTOXIFYLLINE 1 0.0002
2 TEDUGLUTIDE 3 0.0002
3 FLUOCINONIDE TOPICAL SOLUTION USP, 0.05% 1 0.0002
4 DASPONE 1 0.0001
5 DAPSONE GEL, 5% 1 0.0001
6 DAPSONE 1 0.0001
7 LOPERAMIDE HYDROCHLORIDE 4 0.0001
8 STANDARDIZED SENNA CONCENTRATE 1 0.0001
9 MAGNESIUM HYDROXIDE 1 0.0001
See all drugs enriched for association with HYPERVITAMINOSIS B12

HYPERVITAMINOSIS B12 is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Blood Viscosity Reducer [EPC] 1 0.0002
1 GLP-2 Analog [EPC] 3 0.0002
2 Sulfone [EPC] 1 0.0001
3 Progesterone [EPC] 1 0.0000
4 Provitamin D2 Compound [EPC] 1 0.0000
5 Thiazide-like Diuretic [EPC] 1 0.0000
6 Pyrimidine Synthesis Inhibitor [EPC] 1 0.0000
7 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
8 Calcium [EPC] 2 0.0000
9 Arteriolar Vasodilator [EPC] 1 0.0000
See all drug classes enriched for association with HYPERVITAMINOSIS B12